Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks off 2024 with FDA IND Submission for its HYPER-H23-1 Phase 1b Human Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the submission of its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for its HYPER-H23-1 phase 1b hypertension clinical trial. The submission follows a successful pre-IND meeting with the FDA, an integral step in the IND’s […]

Clene Inc. (NASDAQ: CLNN) Revolutionizes Approach to Restore Neuronal Health in Neurodegenerative Disease with CNM-Au8(R)

Neurodegenerative diseases pose a significant challenge in healthcare, yet treatment options remain limited. Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is working on a potentially groundbreaking nanomedicine called CNM-Au8® that aims to revolutionize the approach to addressing nervous system failure associated […]

Sustain SoCal Sustainable Agriculture and Food Systems 2024 – Presents Latest Ag and Food Systems Developments

Sustain SoCal invites regional leaders, regulatory authorities, individuals, and entities in the food and agriculture spectrum, to gather at the Sustainable Agriculture and Food Systems Event on February 20, 2024, and share their journeys, achievements, failures, and shortfalls in the existing system. With seven years in the agricultural space, the event will be attended by […]

SOBRsafe Inc. (NASDAQ: SOBR) Announces SOBRsure(TM) Sales Activities in Australia and New Zealand

SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that it has initiated SOBRsure(TM) sales activities in Australia and New Zealand through an international channel partnership with Drug Testing Business Success – the region’s leading drug and alcohol testing provider. Drug Testing Business Success has extensive experience in the transdermal alcohol […]

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Shares 2023 Company Update and 2024 Roadmap in Annual Letter

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its ambitious plans for the 2024 calendar year. In his annual letter, Chris Bunka, Lexaria’s CEO, noted that this would mark the year that will prove all of the company’s work of producing hard, factual scientific information worth it, accomplishments that were […]

China Rare Earths ‘Crisis’ Spells BIG Opportunity

We’ve known this was coming, for a very long time. For well over a decade, various experts have been warning governments and industry about global over-reliance on China for the supply of rare earth elements (REE). Now, this day of reckoning has arrived. Beginning in the spring of 2023, China first “threatened” to impose restrictions […]

Electronic Servitor Publication Network Inc. (XESP) Combines Powerful Digital Engagement Engine(TM) with Simple Pricing Model to Drive Growth of Client Companies

Electronic Servitor Publication Network (OTCQB: XESP) is a digital engagement company that, through its digital activation and customer engagement solutions, provides B2B companies with intelligent interaction management, dynamic content provisioning, and a logic-driven workflow that creates dynamic digital experiences. Targeting multiple verticals, the company aims to accelerate client companies’ audiences from awareness to action, driving […]

 

From Our Blog

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

August 13, 2026

Aging populations are pushing joint disease higher on the orthopedic agenda, with cartilage damage representing one of the field’s largest unmet needs. Current treatments have demonstrated clinical utility, but they remain difficult to deliver efficiently and economically on scale. That gap is where off-the-shelf therapies can deliver high value, and where manufacturing know-how and intellectual […]

Rotate your device 90° to view site.